HIRATSUKA Masahiro

Affiliation: Graduate School of Pharmaceutical Sciences & Faculty of Pharmaceutical Sciences
Division of Biochemical Pharmacology and Therapeutics
Biochemical Pharmacology and Therapeutics
Laboratory of Pharmacotherapy of Life-style Related Diseases

Research Fields

Academic Society Membership

Original Papers: Functional characterization of 12 allelic variants of CYP2C8 by assessment of paclitaxel 6 alpha-hydroxylation and amodiaquine N-deethylation.[DRUG METABOLISM AND PHARMACOKINETICS,30(5),(2015),366-373]Tsukada, Chiharu Saito, Takahiro Maekawa, Masamitsu Mano, Nariyasu Oda, Akifumi Hirasawa, Noriyasu Hiratsuka, Masahiro
10.1016/j.dmpk.2015.07.003; CYP2A6 genetic polymorphism is associated with decreased susceptibility to squamous cell lung cancer in Japanese smokers.[DRUG METABOLISM AND PHARMACOKINETICS,30(4),(2015),263-268]Hosono, Hiroki Kumondai, Masaki Arai, Tomio Sugimura, Haruhiko Sasaki, Takamitsu Hirasawa, Noriyasu Hiratsuka, Masahiro
10.1016/j.dmpk.2015.04.002; Functional characterization of 20 allelic variants of CYP1A2.[DRUG METABOLISM AND PHARMACOKINETICS,30(3),(2015),247-252]Ito, Miyabi Katono, Yuki Oda, Akifumi Hirasawa, Noriyasu Hiratsuka, Masahiro
10.1016/j.dmpk.2015.03.001; Glucocorticoids decrease the production of glucagon-like peptide-1 at the transcriptional level in intestinal L-cells.[MOLECULAR AND CELLULAR ENDOCRINOLOGY,406(C),(2015),60-67]Sato, Taiki Hayashi, Hiroto Hiratsuka, Masahiro Hirasawa, Noriyasu
10.1016/j.mce.2015.02.014; Genetic Polymorphisms of Dihydropyrimidinase in a Japanese Patient with Capecitabine-Induced Toxicity.[PLOS ONE,10(4),(2015),e0124818-]Hiratsuka, Masahiro Yamashita, Hiroshi Akai, Fumika Hosono, Hiroki Hishinuma, Eiji Hirasawa, Noriyasu Mori, Takahiro
10.1371/journal.pone.0124818

Honours, Awards and Prizes